Report Overview

Advantages & properties of gelatin and the launch of advanced pharma gelatin are expected to boost the growth of UAE Pharmaceutical Gelatin market during the forecast period between 2023 and 2029.

UAE Pharmaceutical Gelatin Market - Industry Trends & Forecast Report, 2029

UAE pharmaceutical gelatin market size was estimated to be worth USD 14.81 million in 2022. During the forecast period between 2023 and 2029, the UAE pharmaceutical gelatin market size is projected to grow at a CAGR of 7.20%, reaching a value of USD 22.47 million by 2029. Major growth factors for the UAE pharmaceutical gelatin market include expanding the pharmaceutical industry along with significant research and development in the sector. Furthermore, the rising geriatric population and increasing awareness regarding its health benefits are projected to offer significant growth opportunities to the UAE pharmaceutical gelatin market.

UAE Pharmaceutical Gelatin Market – Overview

Gelatin is a translucent, colorless protein that is naturally soluble in water. It is a protein made from uncooked animal products. Collagen, the most prevalent protein in the animal kingdom with large amounts seen in connective tissues, is partially hydrolyzed to produce it. Gelatin is utilized as a basic material in emergency medicine to create blood substitutes like plasma expanders. These boost the fluid in the bloodstream, avoiding hypovolemic shock. Gelatin is a protein-rich food that contains amino acids that may improve cognitive function, lessen the effects of aging on the skin, and lessen joint and bone discomfort.

UAE Pharmaceutical Gelatin Market

Growth Drivers

Advantages and Favorable Properties of Gelatin

Hydrogels made of gelatin are employed in tissue engineering and medication delivery because they encourage cell adhesion and growth. The benefit of using gelatin as a drug delivery system is that the therapeutic substance may be injected into the gelatin structure under fairly standard circumstances. Gelatin is an ancient technology with a track record of safety. The ease of manufacturing, accessibility of raw materials, and affordability of gelatin capsules all help to drive market demand in the pharmaceutical sector.

Restraints

Shift toward Non-Gelatin Capsules

The ban on pork products including porcine sourced pharmaceutical gelatin along with rising vegan population in UAE is emerging as a major restraining factor for the market growth. Keeping with the rising demand for non-gelatin capsules, the pharmaceutical companies are shifting towards polymeric materials such as hypromellose and starch for capsule production. With rising addition of capsules made of plant-derived materials into the product portfolio of the pharmaceutical companies, the demand for pharmaceutical gelatin may significantly drop, negatively impacting the UAE market growth.

Impact of COVID-19 on the UAE Pharmaceutical Gelatin Market

The COVID-19 pandemic initially hindered the UAE pharmaceutical gelatin market due to the decline in demand and consumption of animal products. The supply chain restrictions on the pharmaceutical trade also negatively impacted the market growth. However, gelatin emerged as a crucial element in the production of COVID-19 vaccines. In order to stabilize the drug's components and guarantee their effectiveness throughout the distribution process, gelatin derived from pig and cow products is frequently utilized in vaccinations. Although concerns rose regarding the use of pork gelatin in vaccines among the Muslim community of the country, the top Islamic authority in the United Arab Emirates stated on December 23, 2020, that COVID-19 vaccinations are acceptable for Muslims, even if they include pig gelatin.

UAE Pharmaceutical Gelatin Market

Segmental Coverage

UAE Pharmaceutical Gelatin Market – By Source

Based on the source, the UAE pharmaceutical gelatin market is segmented into bovine skin, bovine bone, marine, and poultry. Bovine bone accounts for the largest share of the market. According to a journal published on ScienceDirect, gelatin is extracted from cow bones for use in pharmaceuticals. Collagen is subjected to alkaline and acid hydrolysis to produce type A and type B gelatin, respectively. A wide isoelectric range between pH 7 and 9 is present in type A gelatin. Pharmaceutical gelatin derived from bovine bone and skin is extensively used in the pharma, food, and nutraceutical industry, which contributes to its market growth.

UAE Pharmaceutical Gelatin Market – By Function

Based on function, the UAE pharmaceutical gelatin market is segmented into stabilizing agents, thickening agents, gelling agents, and others. The function of pharmaceutical gelatin as a stabilizing agent holds the highest share in the UAE pharmaceutical gelatin market. Some vaccinations contain a stabilizer made from gelatin that has been properly processed and has minimal endotoxin levels. Some vaccinations contain a stabilizer made from gelatin that has been properly processed and has minimal endotoxin levels. The rising demand for vaccines is directly influencing the demand for pharmaceutical gelatin in the Gulf nation.

UAE Pharmaceutical Gelatin Market – By Type

Based on type, the UAE Pharmaceutical Gelatin market is segmented into type A and type B. The type B segment accounts for the largest market share. This type of gelatin has a higher viscosity and lower bloom strength. Furthermore, Gelatin kind B is a kind of gelatin made from demineralized animal bones and the skins of cattle. It is permitted (Halal) to use gelatin made from the bones of halal-slaughtered cows. This acts as a major factor for its market growth in the UAE, which is predominantly a Muslim country.

UAE Pharmaceutical Gelatin Market – By Application

Based on application, the UAE pharmaceutical gelatin market is segmented into hard capsules, soft-gel capsules, tablets, absorbable hemostats, and others. Hard capsules dominate the UAE pharmaceutical gelatin market. A hard gelatin capsule is a type of capsule that is usually used to contain medicine in the form of dry powder or very small pellets. The growth of this segment is mainly attributed to the rising consumption of oral medications including tablets and hard gelatin capsules. However, soft-gel capsules are projected to register the highest growth rate during the forecast period.

Competitive Landscape

Major players operating in the UAE pharmaceutical gelatin market include Gelita AG, Trobas Pharmaceutical Gelatine B.V, Rousselot, Weishardt, Sterling Gelatin, Catalent, Inc, Nitta Pharmaceutical Gelatin India Limited, Aspire Pharmaceuticals, Junca Gelatines, and Gelco International.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In January 2023 - Niner Pharmaceuticals LLC, headquartered in the UAE, announced its plan to establish a complete supply chain between India and the GCC region.

Scope of the Report

By Source

• Bovine Skin

• Bovine Bone

• Marine

• Poultry

By Function

• Stabilizing Agent

• Thickening Agent

• Gelling Agent

• Others

By Type

• Type A

• Type B

By Application

• Hard Capsules

• Softgel Capsules

• Tablets

• Absorbable Hemostats

• Others